COVID-19 Patients Were Removed From Ventilators Within Ten Days After Two Infusions of Ryoncil
source: pixabay.com

COVID-19 Patients Were Removed From Ventilators Within Ten Days After Two Infusions of Ryoncil

  A recent article in Biospace reported an 83% survival rate for COVID-19 patients after two infusions of the experimental drug Ryoncil, developed by Mesoblast Ltd. The patients who were…

Continue Reading COVID-19 Patients Were Removed From Ventilators Within Ten Days After Two Infusions of Ryoncil
Free Genetic Testing for Lysosomal Storage Diseases Provided by Invitae, Axovant
source: pixabay.com

Free Genetic Testing for Lysosomal Storage Diseases Provided by Invitae, Axovant

  According to Batten Disease News, Invitae and Axovant Gene Therapies partnered up to offer free genetic testing in North America. This will focus on children who are thought to…

Continue Reading Free Genetic Testing for Lysosomal Storage Diseases Provided by Invitae, Axovant
Defective Immune Cells Cause Rare Childhood Neurological Disorders
https://pixabay.com/en/child-cute-dad-father-love-man-1835730/

Defective Immune Cells Cause Rare Childhood Neurological Disorders

A recent University of Sheffield news release explores findings which highlight a potential cause of leukodystrophies: immune cells. This group of rare childhood neurological disorders impacts the myelin sheath, the…

Continue Reading Defective Immune Cells Cause Rare Childhood Neurological Disorders
ICYMI: A New Medical Device Invented by a Patient will Help Prevent Tongue Biting During Seizures
source: pixabay.com

ICYMI: A New Medical Device Invented by a Patient will Help Prevent Tongue Biting During Seizures

By Natalie Homan from In The Cloud Copy It’s estimated that about 3.4 million Americans have epilepsy, one of many conditions that can cause seizures. Seizures occur when there is…

Continue Reading ICYMI: A New Medical Device Invented by a Patient will Help Prevent Tongue Biting During Seizures
Scleroderma Symptoms Shown to Be Alleviated with Tracleer Treatment
source: pixabay.com

Scleroderma Symptoms Shown to Be Alleviated with Tracleer Treatment

by Danielle Bradshaw from In The Cloud Copy A year-long study has shown that Tracleer greatly reduces the skin-related symptoms of scleroderma. The results also showed that although it helped…

Continue Reading Scleroderma Symptoms Shown to Be Alleviated with Tracleer Treatment
RNA Therapy Holds Promise for Treating SMA and Other Rare Diseases
source: pixabay.com

RNA Therapy Holds Promise for Treating SMA and Other Rare Diseases

by Jodee Redmond from In the Cloud Copy   Emma Larson’s parents were not particularly concerned when their daughter wasn’t standing or walking by her first birthday. They figured that plenty of children had not reached…

Continue Reading RNA Therapy Holds Promise for Treating SMA and Other Rare Diseases
One Hundred Vaccines Against COVID-19 Are In Early Stages of Development, But Only a Few Will Survive
source: pixabay.com

One Hundred Vaccines Against COVID-19 Are In Early Stages of Development, But Only a Few Will Survive

A total of one hundred vaccines are being developed by researchers, drug manufacturers, and governments worldwide in an effort to stem the tide of the COVID-19 virus. Reuters Newswire reports…

Continue Reading One Hundred Vaccines Against COVID-19 Are In Early Stages of Development, But Only a Few Will Survive
PTC Therapeutics to Acquire Censa Pharmaceuticals, Developer of an Experimental Phenylketonuria Drug
source: pixabay.com

PTC Therapeutics to Acquire Censa Pharmaceuticals, Developer of an Experimental Phenylketonuria Drug

According to a story from Xconomy, the drug company PTC Therapeutics has come to an agreement that will allow it to acquire Censa Pharmaceuticals and its lead product candidate. This…

Continue Reading PTC Therapeutics to Acquire Censa Pharmaceuticals, Developer of an Experimental Phenylketonuria Drug